Sort
50,496 grants matching “lung cancer”
Protein Kinase Signaling and Cell Cycle Control
$498,230Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2014 · ES
Genetic dissection of oncogenic RAS-driven tumor initiation in vivo
$498,229Christopher M Counter · Duke University · R01 · FY2022 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$498,202John D Gordan · University Of California, San Francisco · R37 · FY2024 · CA
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
$498,192Muneeb Ahmed · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Deriving Bone Density from Thoracic CT Scans, STTR Phase II
$498,127Mike Allen · Bdi, Inc. · R42 · FY2019 · AR
Detection of Prostate Cancer Genomic Signatures in Blood
$498,123Amin I Kassis · Harvard Medical School · RC1 · FY2010 · CA
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)
$498,107John John Schwartz · Acuitybio Corporation · R44 · FY2012 · CA
Molecular and biochemical basis of Lymphangioleiomyomatosis
$498,075John Blenis · Harvard Medical School · R01 · FY2014 · HL
Mechanisms of mutant p53 reactivation
$498,061Peter Kaiser · University Of California-Irvine · R01 · FY2023 · CA
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation
$498,038Drew James Adams · Case Western Reserve University · R01 · FY2025 · AI
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease
$498,026Leslee J Shaw · Emory University · RC1 · FY2009 · HL
Case Control Study of Pancreas Cancer in Shanghai, China
$498,023Harvey A Risch · Yale University · R01 · FY2012 · CA
Pilot Project's Core
$498,023Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2014 · AI
High-resolution ultrasound in-vivo animal imaging system-Vevo2100
$498,000Kang Kim · University Of Pittsburgh At Pittsburgh · S10 · FY2010 · RR
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$497,984Paul Mathew · Tufts Medical Center · R01 · FY2023 · CA
High-Precision Lung Radiotherapy by Intra-treatment Dynamic Cone-beam CT imaging and Dosimetry-guided Plan Adaptation
$497,982You Zhang · Ut Southwestern Medical Center · R01 · FY2024 · EB
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease
$497,966Leslee J Shaw · Emory University · RC1 · FY2010 · HL
Role of IKK alpha in lung cancer development
$497,920Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Regulators of Cancer Immunotherapy Response
$497,881Xiaole Shirley Liu · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Biomarker Development Lab
$497,866Steven M. Dubinett · Boston University Medical Campus · U2C · FY2024 · CA
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring
$497,850Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
$497,819Dejana K Braithwaite · University Of Florida · R01 · FY2024 · CA
New Tools for Prostate Cancer Detection and Prognostication
$497,815Sanjiv S Gambhir · Stanford University · U01 · FY2014 · CA
Tools for Managing and Disseminating Cardiac Electrophysiology Data
$497,790Raimond Lester Winslow · Johns Hopkins University · R01 · FY2011 · HL
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$497,789Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · DE